Beilloso FACIAL BUMP REFINING ESSENCE

Manufacturer
Jiangxi Hemei Pharmaceutical Co., Ltd
Effective date
2025-12-24
Label type
HUMAN OTC DRUG LABEL
Version
2
Source
monthly-update
Hydrated at
2026-06-03 17:46:35

Label at a glance#

ProductBeilloso FACIAL BUMP REFINING ESSENCE
Active ingredientSALICYLIC ACID
Label structure13 sections

Dosage and administration

1. Apply daily after cleansing and toning.Twice a day for at least 4 weeks. 2.Dispense a pea-size amount of the essence onto the problematic area and use fingertips to massage until it is fully absorbed. 3,Keep using it for a period of time untiL the skin papule doesn't appear again.

Storage and handling

For external use only, Stop using and ask a doctor if rash or irritation happens, lf contact with eyes occurs. rinse thoroughly with water, Store in a cool,shady place.

Label contents#

Full prescribing information#

Active Ingredient

OTC - ACTIVE INGREDIENT SECTION

salicylic acid 1%

Purpose

OTC - PURPOSE SECTION

Skin Papule Refining Solution

Use

INDICATIONS & USAGE SECTION

Aids in smoothing skin texture through gentle exfoliation.

Warnings

WARNINGS SECTION

For external use only, Stop using and ask a doctor if rash or irritation happens.

Do not use

OTC - DO NOT USE SECTION

In children less than 2 years old. On open skin wounds.

When Using

OTC - WHEN USING SECTION

When using, keep out of eyes, ears ,mouth and any open broken skin area.In case of contact with eyes, rinse eyes thoroughly with water.

Stop Use

OTC - STOP USE SECTION

Stop using and ask a doctor if irritation or rash occurs.

Ask Doctor

OTC - ASK DOCTOR SECTION

Stop using and ask a doctor if irritation or rash occurs.

Keep Oot Of Reach Of Children

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

Keep out of reach of children. lf swallowed, get medical help or contact the Poison Control Center right away.

Directions

DOSAGE & ADMINISTRATION SECTION

1. Apply daily after cleansing and toning.Twice a day for at least 4 weeks. 2.Dispense a pea-size amount of the essence onto the problematic area and use fingertips to massage until it is fully absorbed. 3,Keep using it for a period of time untiL the skin papule doesn't appear again.

Other information

STORAGE AND HANDLING SECTION

For external use only, Stop using and ask a doctor if rash or irritation happens, lf contact with eyes occurs. rinse thoroughly with water, Store in a cool,shady place.

Inactive ingredients

INACTIVE INGREDIENT SECTION

Water,Glycerin, Dextrin,xanthan Gum,Amylopectin, Tocopheryl Acetate.

PRINCIPAL DISPLAY PANEL

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

11

Product Linked Resources#

Resource, Code type, Value table
ResourceCode typeValueEquivalent identifiersSource image
BarcodeEAN-136974603691931GTIN-13: 6974603691931
EAN-13: 6974603691931
GTIN storage (14 digits): 06974603691931
salicylic acid.jpg

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
dea2eded-d1e7-46bb-9a3d-f8dc20de6277Product name120190408

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 9 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
84010-23484010-234-01

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 7 matching rows.

Source Document#

Source XML

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
4a462032-b6f5-493c-e063-6394a90a3b204609282d-9d8f-3c80-e063-6294a90a410e2026-02-07WarningsExact identifier
spl set id: 4609282d-9d8f-3c80-e063-6294a90a410e

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.